GlaxoSmithKline to Acquire Cellzome for $99M
May 15, 2012
GlaxoSmithKline to Acquire Cellzome for $99M
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Cellzome, GSK Sign $45M Screening Pact
March 10, 2010 / GenomeWeb Daily News - GSK to Buy Cellzome for $99M as Pharma Interest in Chemical Proteomics Continues to Build
May 18, 2012 / ProteoMonitor - UNC Team Takes Proteomic Approach to Study Drug Resistance in Triple-Negative Breast Cancer
April 20, 2012 / ProteoMonitor - Cellzome Snags More Than $3.1M in Grants for EU-, UK-Sponsored Research Initiatives
December 9, 2011 / ProteoMonitor - Proteomic Screen IDs Potential Use for GlaxoSmithKline Inhibitor in Treating Leukemia
October 7, 2011 / ProteoMonitor